DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Zeymer U, Schrage B, Westermann D.
Dual pathway inhibition with low-dose direct factor Xa inhibition after acute coronary syndromes-why is it not used in clinical practice?.
Thromb Haemost 2018;
118 (09) 1528-1534
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.